Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H19N5O3 |
| Molecular Weight | 353.3752 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(CN)=NC2=C1C=CC(=C2)C(=O)N(CCC(O)=O)C3=CC=CC=N3
InChI
InChIKey=WLVSOHFZTKZNMN-UHFFFAOYSA-N
InChI=1S/C18H19N5O3/c1-22-14-6-5-12(10-13(14)21-16(22)11-19)18(26)23(9-7-17(24)25)15-4-2-3-8-20-15/h2-6,8,10H,7,9,11,19H2,1H3,(H,24,25)
| Molecular Formula | C18H19N5O3 |
| Molecular Weight | 353.3752 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:34:45 GMT 2025
by
admin
on
Wed Apr 02 07:34:45 GMT 2025
|
| Record UNII |
1G2Z3YKT62
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1G2Z3YKT62
Created by
admin on Wed Apr 02 07:34:45 GMT 2025 , Edited by admin on Wed Apr 02 07:34:45 GMT 2025
|
PRIMARY | |||
|
144920619
Created by
admin on Wed Apr 02 07:34:45 GMT 2025 , Edited by admin on Wed Apr 02 07:34:45 GMT 2025
|
PRIMARY | |||
|
1015167-29-9
Created by
admin on Wed Apr 02 07:34:45 GMT 2025 , Edited by admin on Wed Apr 02 07:34:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
URINE
|
||
|
PARENT -> METABOLITE |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
URINE
|
